Blue Ridge Bankshares vs Peoples Bancorp
BRBS and PEBO side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BRBS and PEBO compare
Peoples Bancorp is the larger company, worth 3.8 times as much as Blue Ridge Bankshares ($1.4B against $356M).
On earnings, Peoples Bancorp is cheaper: it trades at 11.1× trailing earnings, against 39.7× for Blue Ridge Bankshares.
Peoples Bancorp grew revenue faster over the last twelve months (2.8% versus −5.4% for Blue Ridge Bankshares).
Peoples Bancorp keeps more of each dollar of sales as profit, with a net margin of 136% compared with 11.2% at Blue Ridge Bankshares.
Both pay dividends: Blue Ridge Bankshares yields 15.1% and Peoples Bancorp 4.4%.
Peoples Bancorp scores higher on the StockData Score (15 against 4 for Blue Ridge Bankshares), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BRBS | PEBO |
|---|---|---|
| Size and price | ||
| Market cap | $356M | $1.4B |
| Share price | $3.97 | $37.70 |
| Change, 1 year | −8.1% | 29.7% |
| Change, 5 years | −78.1% | 20.2% |
| Beta (5Y) | −0.31 | 0.03 |
| Employees | 10 | 1,454 |
| StockData Score | ||
| Total score | 4 | 15 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 0 | 0 |
| Performance score | 1 | 4 (better) |
| Health score | 0 | 4 (better) |
| Dividend score | 3 | 5 (better) |
| Valuation | ||
| P/E | 39.7× | 11.1× (better) |
| P/S | 4.2× (better) | 15.2× |
| P/B | – | 1.1× |
| EV/EBITDA | – | 11.5× |
| P/FCF | 16.9× | 7.9× (better) |
| FCF yield | 5.9% | 12.6% (better) |
| Fair value | – | $37.31 |
| Margin of safety | – | −1.0% |
| Growth | ||
| Revenue growth (TTM) | −5.4% | 2.8% (better) |
| Revenue growth, 5Y average | −3.8% | 10.0% (better) |
| Net income growth (TTM) | – | 19.0% |
| EPS growth (TTM) | – | 18.5% |
| EPS growth, 5Y average | −44.3% | 11.6% (better) |
| Profitability | ||
| Operating margin | – | 171% |
| Net margin | 11.2% | 136% (better) |
| FCF margin | 25.1% | 192% (better) |
| Return on equity | – | 10.1% |
| Return on invested capital | – | 7.7% |
| Financial health | ||
| Debt / equity | – | 0.57 |
| Net debt / EBITDA | – | 2.65 |
| Altman Z-score | 0.11 | 0.23 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 15.1% (better) | 4.4% |
| Payout ratio | – | 49.1% |
| Years of dividend growth | – | 8 |
| Dividend growth, 5Y average | – | 3.5% |
| Buyback yield | – | −0.07% |
| Shareholder yield | 15.1% (better) | 4.4% |
| Ownership | ||
| Held by institutions | 36.4% | 66.0% |
| Held by insiders | 38.8% | 3.8% |
| Insider net buying, 12 months | – | −$455K |
| Short interest, % of float | 2.7% | 8.4% |
Go deeper
- BRBS stock overview
- BRBS income statement
- BRBS valuation and score
- PEBO stock overview
- PEBO income statement
- PEBO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.